Answers are grounded in this paper and cite their sources.
Shows diverse antimicrobial resistance in Mycoplasma bovis, highlighting the need for integrated monitoring.
Mycoplasma bovis is an increasingly important contributor to bovine respiratory disease (BRD), with limited therapeutic options and growing concerns about emerging antimicrobial resistance (AMR). We combined phenotypic susceptibility testing with whole-genome sequencing to characterize circulating lineages, resistance phenotypes, and genomic features among Australian beef feedlot-derived M. bovis isolates. Fifty-five isolates recovered from BRD cases across multiple Australian feedlots in four Australian states (2018–2023) underwent minimum inhibitory concentration (MIC) testing for seven antimicrobial classes and short-read sequencing; nine isolates were additionally long-read sequenced to resolve genomic features. Comparative analyses included 93 publicly available Australian M. bovis genomes (total n = 148). We assessed population structure, gene presence/absence, core single-nucleotide polymorphism (SNP) diversity, unitig/SNP genome-wide association studies (GWAS), copy number, and structural variations. The collection consisted of a single lineage—ST52. Heterogeneous antibiogram phenotypes were evident from MIC testing; however, significant temporal increases in MIC were noted for tetracycline, gamithromycin, and tulathromycin for isolates obtained in 2018–2019 compared to 2020–2023. High tildipirosin, tilmicosin, and florfenicol MICs were obtained for close to 50% of the isolates, whereas enrofloxacin retained low MICs. Long-read assemblies identified five recurrent genomic islands enriched for insertion sequences and variable surface lipoproteins; one island carried an integrative conjugative element (ICE)-like conjugation machinery. Macrolide resistance mapped primarily to 23S rRNA substitutions, including A2059C associated with high-level resistance, with additional context-dependent variants (e.g., T1279C) showing epistatic effects. Elevated tetracycline MICs could not be associated with consistent genetic determinants. Integrated surveillance combining routine MIC monitoring, short-read genomics, and targeted long-read resolution supports antimicrobial stewardship and helps preserve limited therapeutic options. IMPORTANCE Mycoplasma bovis is a major contributor to bovine respiratory disease, yet control remains limited by reduced antimicrobial effectiveness. By integrating minimum inhibitory concentration (MIC) testing with short‑ and long-read genomics, we show that Australian feedlot isolates belong to a dominant, globally distributed ST52 lineage that spans a broad anatomical niche range, with close relatives recovered from mastitis, ocular, joint, and reproductive tract infections. Despite this genomic cohesion, there was heterogeneity in susceptibility and significant temporal increases in MICs for key drugs. Reduced macrolide susceptibility was attributable to 23S rRNA substitutions, with allele context and rRNA copy state determining high‑level resistance. In contrast, elevated tetracycline MICs lacked a consistent genetic marker, underscoring the need for functional and regulatory studies. Long‑read assemblies revealed recurrent genomic islands, including an integrative conjugative like element (ICE), offering a mechanism for rapid phenotypic change. These findings highlight the adaptability of ST52 and underscore the need for integrated MIC‑plus‑genomics surveillance to support antimicrobial stewardship.
No takes yet. Share an insight, caveat, or question.
Jarocki et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: